Literature DB >> 1708310

Activation of macrophages for ADCC in vitro: effects of IL-4, TNF, interferons-alpha/beta, interferon-gamma, and GM-CSF.

S Fan1, H G Fehr, D Adams.   

Abstract

Macrophages in varying states of activation differ in their ability to perform antibody-dependent cellular cytotoxicity (ADCC) and antibody-independent macrophage-mediated tumor cytotoxicity (MTC). To define further the activation requirements for macrophages to perform various cytolytic functions, we stimulated peptone-elicited peritoneal macrophages, which are only poorly cytolytic, with one of a panel of cytokines and then quantified three distinct cytolytic capacities. The peptone-elicited macrophages, after stimulation with IFN-alpha/beta, IL-4, or TNF, had increased ability to perform both the rapid and slow variants of ADCC but not to perform MTC. Stimulation with high doses of IFN-gamma, however, increased the macrophages' ability to perform all three cytolytic functions. GM-CSF had no effects on any cytolytic capacity. The effects of IL-4, TNF, IFN-gamma, and IFN-alpha/beta on the macrophages' capacity for both forms of ADCC were dose-dependent. IFN-gamma and IFN-alpha/beta increased the macrophages' capacity for both variants of ADCC within 4 hr of treatment, whereas IL-4 and TNF did so only after prolonged treatment. These results suggest that three forms of macrophage cytolytic capacity can be enhanced by cytokine treatment but that the requirements for enhancing each of the three forms of macrophage cytolytic capacity differ.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1708310     DOI: 10.1016/0008-8749(91)90255-a

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  12 in total

1.  Vaccine-induced serum immunoglobin contributes to protection from herpes simplex virus type 2 genital infection in the presence of immune T cells.

Authors:  L A Morrison; L Zhu; L G Thebeau
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

2.  Lipopolysaccharide enhances FcgammaR-dependent functions in vivo through CD11b/CD18 up-regulation.

Authors:  C Rubel; P Miliani De Marval; M Vermeulen; M A Isturiz; M S Palermo
Journal:  Immunology       Date:  1999-07       Impact factor: 7.397

3.  Fc gamma receptor-dependent clearance is enhanced following lipopolysaccharide in vivo treatment.

Authors:  M S Palermo; F Alves Rosa; G Fernández Alonso; M A Isturiz
Journal:  Immunology       Date:  1997-12       Impact factor: 7.397

4.  Pulmonary immunity to Pseudomonas aeruginosa in intestinally immunized rats roles of alveolar macrophages, tumor necrosis factor alpha, and interleukin-1 alpha.

Authors:  A Buret; M L Dunkley; G Pang; R L Clancy; A W Cripps
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

5.  A possible role for lysozyme in determining acute exacerbation in chronic bronchitis.

Authors:  D C Taylor; A W Cripps; R L Clancy
Journal:  Clin Exp Immunol       Date:  1995-11       Impact factor: 4.330

6.  Upregulation of tumor necrosis factor alpha and interleukin-1 beta in Q fever endocarditis.

Authors:  C Capo; F Zugun; A Stein; G Tardei; H Lepidi; D Raoult; J L Mege
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

7.  Susceptibility of rhabdomyosarcoma cells to macrophage-mediated cytotoxicity.

Authors:  Delia Herrmann; Guido Seitz; Jörg Fuchs; Sorin Armeanu-Ebinger
Journal:  Oncoimmunology       Date:  2012-05-01       Impact factor: 8.110

8.  Morphological and Functional Alterations of Alveolar Macrophages in a Murine Model of Chronic Inflammatory Lung Disease.

Authors:  Julia Désirée Boehme; Sabine Pietkiewicz; Inna Lavrik; Andreas Jeron; Dunja Bruder
Journal:  Lung       Date:  2015-08-30       Impact factor: 2.584

9.  Role of Acetylsalicylic Acid in Cytokine Stimulation of Macrophages in Antibody-Dependent Cellular Cytotoxicity (ADCC).

Authors:  M Jäpel; H Lötzerich; K Rogalla
Journal:  Mediators Inflamm       Date:  1994       Impact factor: 4.711

10.  Large extracellular loop of tetraspanin as a potential vaccine candidate for filariasis.

Authors:  Gajalakshmi Dakshinamoorthy; Gnanasekar Munirathinam; Kristen Stoicescu; Maryada Venkatarami Reddy; Ramaswamy Kalyanasundaram
Journal:  PLoS One       Date:  2013-10-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.